breast tumor
Conditions
Interventions
A :0.375% ropivacaine 30ml+2ml 0.9%NS
Group B:0.375% ropivacaine 30ml+10mg dexamethasone (2ml)
Sponsors
Fudan University Shanghai Cancer Centre, Department of Oncology, Shanghai Medical College Fudan University
Eligibility
Sex/Gender
Female
Age
18 Years to 100 Years
Inclusion criteria
Inclusion criteria: 1. Patients who signed informed consent, indicated a wish to cooperate with the plan of the study; 2. The ambulatory surgery patients, aged between 35 and 44, unilateral breast tumor resection performed under intercostals nerve block.
Exclusion criteria
Exclusion criteria: 1. diabetes, congenital neuromuscular diseases; 2. BMI>30kg/m2; 3. patients with chronic pain, use analgesics over the past two weeks; 4. allergic to ropivacaine or dexamethasone; 5. patients have participated other clinical trial; 6. blood coagulation dysfunction; 7. congestive heart failure; 8. sepsis or tumor close to site of puncture.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| the onset time of anesthesia;adverse events;VAS pain score;high;weight;age;anesthesia recovery time;the time adverse events happen; | — |
Countries
China
Contacts
Public ContactChanghong Miao
Fudan University Shanghai Cancer Centre, Department of Oncology, Shanghai Medical College Fudan University
Outcome results
None listed